PITRM1
Basic information
Region (hg38): 10:3137728-3172841
Links
Phenotypes
GenCC
Source:
- spinocerebellar ataxia, autosomal recessive 30 (Limited), mode of inheritance: AR
- spinocerebellar ataxia, autosomal recessive 30 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spinocerebellar ataxia, autosomal recessive 30 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 26697887; 29764912; 33835239 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PITRM1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 52 | 12 | 67 | |||
missense | 119 | 25 | 21 | 165 | ||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 6 | 2 | 10 | ||
non coding | 19 | 17 | 37 | |||
Total | 0 | 0 | 125 | 97 | 50 |
Variants in PITRM1
This is a list of pathogenic ClinVar variants found in the PITRM1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-3138032-C-T | Likely benign (Jan 16, 2024) | |||
10-3138035-T-C | Benign (Feb 01, 2024) | |||
10-3138052-G-A | Likely benign (Sep 02, 2022) | |||
10-3138075-C-T | not specified | Uncertain significance (May 08, 2023) | ||
10-3138082-G-A | Likely benign (Oct 16, 2023) | |||
10-3138084-G-T | not specified | Uncertain significance (Dec 14, 2021) | ||
10-3138096-C-T | PITRM1-related disorder | Benign (Jan 25, 2024) | ||
10-3138097-G-A | Likely benign (Dec 13, 2018) | |||
10-3138100-T-C | Likely benign (Sep 26, 2023) | |||
10-3138106-C-T | PITRM1-related disorder | Benign (Feb 01, 2024) | ||
10-3138118-G-A | Likely benign (Jul 26, 2021) | |||
10-3138124-T-C | Benign (Feb 01, 2024) | |||
10-3138142-G-A | Benign (Jul 18, 2023) | |||
10-3138221-C-T | Benign (Jan 22, 2024) | |||
10-3138225-C-T | Likely benign (Jan 06, 2024) | |||
10-3138239-C-G | not specified | Uncertain significance (Aug 23, 2022) | ||
10-3138245-C-T | not specified | Uncertain significance (Feb 27, 2024) | ||
10-3138248-C-T | Uncertain significance (Oct 30, 2023) | |||
10-3138249-C-T | Likely benign (Apr 01, 2024) | |||
10-3138260-C-G | not specified | Uncertain significance (Dec 06, 2023) | ||
10-3138260-C-T | not specified | Uncertain significance (Nov 14, 2023) | ||
10-3138264-G-A | Likely benign (Aug 17, 2023) | |||
10-3138265-C-G | not specified | Uncertain significance (Mar 01, 2023) | ||
10-3138265-C-T | Uncertain significance (Dec 07, 2021) | |||
10-3138269-C-G | Uncertain significance (Apr 01, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PITRM1 | protein_coding | protein_coding | ENST00000380989 | 27 | 35084 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.93e-21 | 0.456 | 124464 | 0 | 184 | 124648 | 0.000738 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.837 | 653 | 596 | 1.10 | 0.0000349 | 6808 |
Missense in Polyphen | 199 | 202.42 | 0.98308 | 2350 | ||
Synonymous | -2.68 | 302 | 248 | 1.22 | 0.0000172 | 1926 |
Loss of Function | 1.93 | 40 | 55.5 | 0.721 | 0.00000272 | 657 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00257 | 0.00256 |
Ashkenazi Jewish | 0.000103 | 0.0000994 |
East Asian | 0.000895 | 0.000890 |
Finnish | 0.000331 | 0.000325 |
European (Non-Finnish) | 0.000833 | 0.000823 |
Middle Eastern | 0.000895 | 0.000890 |
South Asian | 0.000726 | 0.000719 |
Other | 0.000330 | 0.000330 |
dbNSFP
Source:
- Function
- FUNCTION: Metalloendopeptidase of the mitochondrial matrix that functions in peptide cleavage and degradation rather than in protein processing (PubMed:10360838, PubMed:16849325, PubMed:19196155, PubMed:24931469). Has an ATP-independent activity (PubMed:16849325). Specifically cleaves peptides in the range of 5 to 65 residues (PubMed:19196155). Shows a preference for cleavage after small polar residues and before basic residues, but without any positional preference (PubMed:10360838, PubMed:19196155, PubMed:24931469). Degrades the transit peptides of mitochondrial proteins after their cleavage (PubMed:19196155). Also degrades other unstructured peptides (PubMed:19196155). It is also able to degrade amyloid-beta protein 40, one of the peptides produced by APP processing, when it accumulates in mitochondrion (PubMed:16849325, PubMed:24931469). It is a highly efficient protease, at least toward amyloid-beta protein 40 (PubMed:24931469). Cleaves that peptide at a specific position and is probably not processive, releasing digested peptides intermediates that can be further cleaved subsequently (PubMed:24931469). {ECO:0000269|PubMed:10360838, ECO:0000269|PubMed:16849325, ECO:0000269|PubMed:19196155, ECO:0000269|PubMed:24931469}.;
Recessive Scores
- pRec
- 0.173
Intolerance Scores
- loftool
- 0.982
- rvis_EVS
- 3.22
- rvis_percentile_EVS
- 99.36
Haploinsufficiency Scores
- pHI
- 0.0999
- hipred
- N
- hipred_score
- 0.282
- ghis
- 0.409
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.655
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | High | Medium | High |
Mouse Genome Informatics
- Gene name
- Pitrm1
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype;
Gene ontology
- Biological process
- proteolysis;protein targeting to mitochondrion;protein processing;positive regulation of catalytic activity
- Cellular component
- mitochondrion;mitochondrial matrix
- Molecular function
- metalloendopeptidase activity;enzyme activator activity;metallopeptidase activity;zinc ion binding